Healthcare provider profile · identity verified

Emmanuel Logiadis, MD

Internal Medicine · TRUMBULL, CT · NPI 1801874474

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	513	136
Atorvastatin Calcium	Atorvastatin Calcium	469	140
Alprazolam	Alprazolam	285	65
Lisinopril	Lisinopril	283	82
Rosuvastatin Calcium	Rosuvastatin Calcium	270	89
Pantoprazole Sodium	Pantoprazole Sodium	229	51
Levothyroxine Sodium	Levothyroxine Sodium	219	66
Tramadol Hcl	Tramadol Hcl	199	32
Losartan Potassium	Losartan Potassium	198	58
Metformin Hcl	Metformin Hcl	183	50
Omeprazole	Omeprazole	177	49
Montelukast Sodium	Montelukast Sodium	168	52
Metoprolol Succinate	Metoprolol Succinate	153	53
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	153	22
Furosemide	Furosemide	152	40
Ozempic	Semaglutide	138	21
Tamsulosin Hcl	Tamsulosin Hcl	134	41
Fluticasone Propionate	Fluticasone Propionate	126	39
Gabapentin	Gabapentin	126	37
Oxycodone Hcl	Oxycodone Hcl	117	13
Allopurinol	Allopurinol	116	29
Sertraline Hcl	Sertraline Hcl	111	37
Farxiga	Dapagliflozin Propanediol	110	21
Zolpidem Tartrate	Zolpidem Tartrate	107	23
Chlorthalidone	Chlorthalidone	105	27
Eliquis	Apixaban	102	23
Lorazepam	Lorazepam	102	19
Simvastatin	Simvastatin	102	26
Escitalopram Oxalate	Escitalopram Oxalate	97	35
Ezetimibe	Ezetimibe	97	24
Pravastatin Sodium	Pravastatin Sodium	97	25
Hydrochlorothiazide	Hydrochlorothiazide	96	37
Pioglitazone Hcl	Pioglitazone Hcl	92	25
Alendronate Sodium	Alendronate Sodium	81	16
Albuterol Sulfate Hfa	Albuterol Sulfate	79	32
Celecoxib	Celecoxib	79	28
Clopidogrel	Clopidogrel Bisulfate	79	20
Trazodone Hcl	Trazodone Hcl	79	28
Carvedilol	Carvedilol	75	28
Nebivolol Hcl	Nebivolol Hcl	72	22
Famotidine	Famotidine	71	19
Prednisone	Prednisone	71	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	26
Linzess	Linaclotide	63	12
Finasteride	Finasteride	56	18
Januvia	Sitagliptin Phosphate	56	13
Bupropion Xl	Bupropion Hcl	55	19
Symbicort	Budesonide/Formoterol Fumarate	54	suppressed
Clonazepam	Clonazepam	52	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	52	18
Glipizide Er	Glipizide	51	17
Metformin Hcl Er	Metformin Hcl	51	18
Valsartan	Valsartan	51	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	49	19
Mirtazapine	Mirtazapine	49	16
Janumet Xr	Sitagliptin Phos/Metformin Hcl	45	14
Potassium Chloride	Potassium Chloride	45	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	42	12
Clonidine Hcl	Clonidine Hcl	41	suppressed
Jardiance	Empagliflozin	40	15
Meloxicam	Meloxicam	40	11
Glimepiride	Glimepiride	36	11
Lidocaine	Lidocaine	36	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	35	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	34	suppressed
Diazepam	Diazepam	34	suppressed
Azithromycin	Azithromycin	33	27
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Baclofen	Baclofen	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	16
Tresiba Flextouch U-100	Insulin Degludec	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	12
Enalapril Maleate	Enalapril Maleate	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Dexlansoprazole Dr	Dexlansoprazole	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	22	suppressed
Topiramate	Topiramate	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Glipizide	Glipizide	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Colesevelam Hcl	Colesevelam Hcl	18	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Lactulose	Lactulose	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Trintellix	Vortioxetine Hydrobromide	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Fentanyl	Fentanyl	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Praluent Pen	Alirocumab	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Single Use Swab	Alcohol Antiseptic Pads	12	suppressed
Torsemide	Torsemide	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Atenolol	Atenolol	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	11	suppressed
Nyamyc	Nystatin	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error